Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
01 2Polfa Tarchomin
02 12care4
03 1Abacus Medicine
04 2Actavis Inc
05 1Aurobindo Pharma Limited
06 2Austell Laboratories
07 1Brown & Burk
08 2GALDERMA LABS LP
09 1GSK
10 7Galderma
11 1Hiral Labs
12 1Karo Pharma
13 2Neogen N.V.
14 4ORIFARM GROUP AS
15 2Titan Laboratories
01 4CAP
02 2CAPSULE
03 15Capsule
04 4Capsule, hard
05 2Hard Capsule
06 2Limeciclina 408Mg 28 Combined Oral Use
07 1Blank
01 1Allowed
02 5Approved
03 4Deregistered
04 2Dossier Availability: Q3 2025
05 4Generic
06 2Originator
07 2Temporarily Withdrawn
08 10Blank
01 1Leciclina
02 1Lymac 300mg
03 1Lyme Lysal
04 2Lymecyclin Actavis
05 1Lymecycline 300 mg Unicorn
06 1Lymecycline Abacus Medicine
07 1Lymecycline Actavis
08 1Lymecycline Brown & Burk
09 1Lymecycline Glenmark
10 1Lymecycline Orifarm
11 12Tetralysal
12 7Blank
01 2Canada
02 3India
03 3Italy
04 4Norway
05 2Poland
06 4South Africa
07 11Sweden
08 1Switzerland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2025
Registration Country : Poland
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2025
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2025
Registration Country : Poland
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2025
Registration Country : Poland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lymecycline Abacus Medicine
Dosage Form : Capsule
Dosage Strength : 300mg
Packaging :
Approval Date : 30/01/2025
Application Number : 20241017000018
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Lymecyclin Actavis
Dosage Form : Capsule, hard
Dosage Strength : 300 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Lymecyclin Actavis
Dosage Form : Capsule, hard
Dosage Strength : 300 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Italy
Brand Name : Leciclina
Dosage Form : Limeciclina 408Mg 28 Combined Oral Use
Dosage Strength : 28 cps 408 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Tetralysal
Dosage Form : Limeciclina 408Mg 28 Combined Oral Use
Dosage Strength : 28 cps 300 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Tetralysal
Dosage Form :
Dosage Strength : 28 Cps 150 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Tetralysal
Dosage Form : Capsule, hard
Dosage Strength : 300 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Tetralysal
Dosage Form : Capsule, hard
Dosage Strength : 300 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Tetralysal
Dosage Form : Capsule
Dosage Strength : 150mg
Packaging :
Approval Date : 17/02/1964
Application Number : 19640217000011
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Tetralysal
Dosage Form : Capsule
Dosage Strength : 300mg
Packaging :
Approval Date : 29/08/1969
Application Number : 19690829000039
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lymecycline Glenmark
Dosage Form : Capsule
Dosage Strength : 300mg
Packaging :
Approval Date : 22/04/2022
Application Number : 20210121000016
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 408mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lymecycline Actavis
Dosage Form : Capsule
Dosage Strength : 300mg
Packaging :
Approval Date : 14/12/2012
Application Number : 20120106000040
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Lymecycline Orifarm
Dosage Form : Capsule
Dosage Strength : 300mg
Packaging :
Approval Date : 15/02/2017
Application Number : 20160701000151
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
